Transgene expands ProBioGen partnership with new AGE1.CR.pIX cell line license

Reuters2026/09/08 05:30

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Transgene expanded its strategic partnership with ProBioGen through an additional license for the AGE1.CR.pIX suspension cell line.
Deal targets improved manufacturing scalability for virus-based immunotherapies, supporting higher productivity and lower-cost, more reliable production.
AGE1.CR.pIX is a GMP-qualified continuous cell line grown in chemically defined, animal-component-free medium to support reproducible batch starts.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transgene SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609080130PRIMZONEFULLFEED1001261432) on September 08, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Transgene expands ProBioGen partnership with new AGE1.CR.pIX cell line license

You may also like

Crypto prices